Bihar kids fall sick after eating mid day meal
The Central Government has imposed restrictions on the manufacture, sale, and distribution of all fixed-dose combination (FDC) medicines containing Chlorpheniramine Maleate and Phenylephrine Hydrochloride for children below four years of age. The notification mandates that these medicines must not be used in children under the age of four.
The latest order expands an earlier notification issued on April 15, 2025, which had applied the same age-specific warning to certain FDCs containing these ingredients. The new notification now covers all formulations with this combination.
The decision was taken following recommendations from an expert committee and the Drugs Technical Advisory Board (DTAB). The government said that the combination of Chlorpheniramine Maleate and Phenylephrine Hydrochloride may pose health risks to children below four years of age, prompting the stricter safety warning.
Addressing the 2nd ICC Medical Education Forum, organised by the Indian Chamber of Commerce (ICC) in association…
The National Medical Commission has proposed a centrally generated unique identification number for every registered…
Union Health Minister J P Nadda on Friday reviewed the prevailing H1N1 influenza situation and…
Union Health Minister JP Nadda was admitted to AIIMS Delhi following the complaint of breathing…
India has achieved a milestone in organ transplantation, recording its highest-ever number of transplants in…
Mothers Against Vaping (MAV), a collective of mothers worried about the future of their children,…